Related Experiment Video
Updated: Dec 12, 2025

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Health economics: the start of clinical freedom
José Antonio Sacristán1, María Costi, Amparo Valladares
1Clinical Research Department, Eli Lilly and Company, Avenida de la Industria 30, Alcobendas, 28108 Madrid, Spain. sacristan_jose@lilly.com
Background:
Since Professor Hampton announced the death of clinical freedom in 1983, the increasing influence of Evidence-based Medicine and Health Technology Assessment has contributed to augment the feeling that clinicians have a secondary role in the therapeutic decision-making process.
Discussion:
This article constitutes a reflection on how clinicians may use the results of economic evaluations in their daily clinical practice, making decisions about cost-effectiveness on a case by case basis, and addressing both the patient's and society's needs. To that end, some illustrating examples are taken from the literature to show there are factors with great impact on cost-effectiveness results that can be easily identified and modified by clinicians.
Summary:
The evolution of the discipline and the trend towards a tailored therapy suggest that health economics is not the end of clinical freedom but the start of it.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Introduction to Epidemiology
Ethics and Bioethics

